瀏覽其他金融產品
Abbott Laboratories
ABT重點摘要
最後更新: 2026-04-16- •Abbott trimmed 2026 EPS guidance to $5.38–$5.58 from $5.55–$5.80 due to ~$21B Exact Sciences acquisition dilution.
- •ABT dropped 6.90% to $94.53, extending a 19% YTD decline — a high-volatility environment for leveraged CFD traders.
- •A 50x long ABT CFD opened at the 24h high of $98.97 faces a ~224% margin loss at current prices, well past liquidation thresholds.
- •Healthcare peers including Johnson & Johnson, AbbVie, and Medtronic face sympathy pressure as M&A integration risk repricing spreads.
- •Abbott maintained 6.5%–7.5% sales growth guidance — the sole bullish anchor that may limit downside if integration news improves.
價格及市場結構
市況形態狀態
最新動態
雅培因精確科學交易稀釋下調2026獲利預測 — ABT CFD交易者面臨清算風險
根據《商業時報》的報導,雅培實驗室將其2026年調整後每股盈餘預測下調至每股$5.38至$5.58,先前預測範圍為$5.55至$5.80。此次下調反映了由於完成了約210億美元收購癌症篩檢公司精確科學所帶來的短期獲利稀釋,該交易於2026年4月16日完成。雅培的主打產品Cologuard結腸篩檢測預計在2026年的營收貢獻約30億美元,但交易整合成本正在壓縮利潤率。截至最新交易時段,ABT股票下跌
雅培公司財報不及預期觸發10%大跌:槓桿風險與醫療行業影響
雅培公司(ABT)於2026年1月22日發布2025年第四季財報,營收不及預期,公告後股價下跌約10%,創下52週低點。根據Barchart,第四季營收為$114.6億,低於華爾街的預期,而調整後每股盈餘(EPS)為$1.50,符合預期。營收疲弱主要集中在營養品(報告銷售-8.9%)和診斷部門(-2.5%),後者受到COVID-19檢測量下降的拖累。ABT對2026年有機銷售增長的指引為6.5%-
艾伯特實驗室2025年第一季:每股盈餘超出預期和利潤擴張驅動5%的漲幅,但營收未達預期和外幣風險影響前景
艾伯特實驗室(ABT)於2025年4月16日公布2025年第一季的財報,結果顯示出雜混但大致正面的季度表現。根據艾伯特的官方新聞稿,調整後每股盈餘為1.09美元,超出市場預期的1.07美元——同比增長11%——而營收為103.58億美元,稍微低於預期的104億美元。關於ABT "降低2026年調整後利潤預期" 的報導似乎與確定事實不符:儘管面臨關稅阻力,公司實際上重申了其2025年的全年指導,並在
Get Started with Abbott Laboratories
Start trading Abbott Laboratories on CoinUnited.io with industry-leading leverage and zero fees.
Trade with Leverage
Trade ABT CFDs with up to 1000x leverage on CoinUnited.io.
- Up to 1000x leverage
- Zero trading fees
- Advanced risk management tools
Explore Stocks
Browse the full stocks market on CoinUnited.io with 125+ instruments.
- 125+ stocks instruments
- Real-time market data
- Professional charting tools
Learn Stocks Trading
Read our in-depth research and analysis on stocks markets.
- Expert market analysis
- Technical analysis basics
- Daily market insights
How to Trade Abbott Laboratories: Step-by-Step Guide
Learn how to trade Abbott Laboratories (ABT) on CoinUnited.io with up to 1000x leverage and zero trading fees. Follow this simple step-by-step guide to start CFD trading today.
Create Your CoinUnited.io Account
Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.
- ✓Quick and free registration
- ✓Email and password setup
- ✓Two-factor authentication for security
Verify Your Identity
Complete the KYC verification process to unlock full trading features and higher limits.
- ✓Upload government-issued ID
- ✓Proof of address document
- ✓Usually verified within minutes
Deposit Funds
Fund your account using one of the supported deposit methods.
Deposit Methods
- •Cryptocurrency deposits (BTC, ETH, USDT)
- •Bank transfer available
- •No minimum deposit requirement
Find ABT in the Stocks Section
Navigate to the stocks market section and search for ABT. You can trade Abbott Laboratories as a CFD with up to 1000x leverage.
- ✓Search for "ABT" in the trading platform
- ✓Select CFD trading mode
- ✓Review the current price and market data
Place Your Trade
Choose your position direction (long or short), set your leverage, and enter your position size to trade Abbott Laboratories.
- ✓Long (buy) if you expect ABT to rise
- ✓Short (sell) if you expect ABT to fall
- ✓Set stop-loss and take-profit levels
Monitor & Manage Risk
Keep track of your open positions and manage risk with stop-loss orders and position sizing.
- ✓Monitor P&L in real-time
- ✓Adjust stop-loss as needed
- ✓Never risk more than you can afford to lose
Order Types
Market Order
Execute immediately at the current market price. Best for quick entries.
Limit Order
Set a specific price to enter. The order fills only when the market reaches your price.
Stop-Loss Order
Automatically close your position at a specified price to limit potential losses.
Important Tips
- • Start with a small position to understand how leverage works
- • Always set a stop-loss to protect your capital
- • Higher leverage amplifies both gains and losses
- • Never invest more than you can afford to lose
標籤
免責聲明與參考資料
重要風險提示
本平台所載全部 Abbott Laboratories 價格預測與展望僅供資訊及教育用途,並不構成任何形式的財務建議、投資推薦或指引。
加密貨幣市場波動極高且難以預測,過去表現不代表未來結果。上述預測基於數學模型、歷史數據分析及各類技術指標,無法涵蓋不可預見的市場事件、監管變動或其他外部因素。
用戶在作出任何投資決策前,應自行研究並諮詢合資格的財務專業人士。本平台之創建者及營運者概不承擔因依賴相關資訊而導致的任何財務損失或其他損害責任。
投資加密貨幣風險極高,可能損失全部本金。
方法論概覽
我們的 Abbott Laboratories 價格預測採用多因素模型,結合:
- 技術分析(移動平均線、震盪指標、圖表形態)
- 機器學習模型(LSTM 網絡、迴歸模型)
- 鏈上指標(交易量、活躍地址、交易所流向)
- 情緒分析(社交媒體、新聞、群眾心理)
- 宏觀因素(通脹、利率、與傳統市場的相關性)
方法論最後審閱日期:
準備好開始交易 Abbott Laboratories 了嗎?
加入數千名交易者,今天就開始您的 Abbott Laboratories 交易之旅。獲得先進的交易工具和具競爭力的費用。
ABT
Abbott Laboratories
Live from CoinUnited.io